Overview
Agne Paner is a Hematologist Oncology specialist and a Hematologist in Maywood, Illinois. Dr. Paner is rated as an Advanced provider by MediFind in the treatment of Secondary Systemic Amyloidosis. Her top areas of expertise are Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Smoldering Multiple Myeloma, and Bone Marrow Aspiration.
Her clinical research consists of co-authoring 20 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Loyola University Medical Center
Kevin Barton is a Hematologist Oncology specialist and a Hematologist in Maywood, Illinois. Dr. Barton is rated as a Distinguished provider by MediFind in the treatment of Secondary Systemic Amyloidosis. His top areas of expertise are Beta Thalassemia, Shwartzman Phenomenon, Non-Hodgkin Lymphoma, Aplastic Anemia, and Bone Marrow Aspiration. Dr. Barton is currently accepting new patients.
Affiliated Oncologists, LLC
Mouhammed Kelta is a Hematologist and an Oncologist in Chicago Ridge, Illinois. Dr. Kelta is rated as an Advanced provider by MediFind in the treatment of Secondary Systemic Amyloidosis. His top areas of expertise are Childhood Acute Myeloid Leukemia, Thrombocytopenia, Deep Vein Thrombosis, Pulmonary Embolism, and Bone Marrow Aspiration.
Rush University Medical Group
Sunita Nathan is a Hematologist Oncology specialist and a Hematologist in Chicago, Illinois. Dr. Nathan is rated as a Distinguished provider by MediFind in the treatment of Secondary Systemic Amyloidosis. Her top areas of expertise are Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Graft. Dr. Nathan is currently accepting new patients in some locations.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Multiple MyelomaDr. Paner isElite. Learn about Multiple Myeloma.
- Distinguished
- Large-Cell Immunoblastic LymphomaDr. Paner isDistinguished. Learn about Large-Cell Immunoblastic Lymphoma.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Relapsed Refractory Multiple Myeloma (RRMM)
- Schnitzler SyndromeDr. Paner isDistinguished. Learn about Schnitzler Syndrome.
- Smoldering Multiple MyelomaDr. Paner isDistinguished. Learn about Smoldering Multiple Myeloma.
- ThrombocytopeniaDr. Paner isDistinguished. Learn about Thrombocytopenia.
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Paner isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Paner isAdvanced. Learn about Agranulocytosis.
- Bone Marrow AspirationDr. Paner isAdvanced. Learn about Bone Marrow Aspiration.
- Lung CancerDr. Paner isAdvanced. Learn about Lung Cancer.
- PlasmacytomaDr. Paner isAdvanced. Learn about Plasmacytoma.
- Experienced
- Acute Eosinophilic PneumoniaDr. Paner isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Mountain SicknessDr. Paner isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Adult Immune ThrombocytopeniaDr. Paner isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Paner isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer